Eli Lilly is expanding its private financing ambitions, partnering with venture capital firm Andreessen Horowitz on a new ...

Eli Lilly in talks to acquire cancer biotech Scorpion Therapeutics for $2.5 billion, with potential milestone payments.

Venture capital firm Andreessen Horowitz said on Friday it was working with Eli Lilly to launch a $500 million venture fund that will be fully funded by the U.S. drugmaker.

Eli Lilly and venture capital firm Andreessen Horowitz (a16z) are joining forces to create a unique new fund dubbed the ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Eli Lilly has been operating a global capability center (GCC) in Bengaluru, India. | For nearly a decade, Eli Lilly has been operating a global capability center (GCC) in Bengaluru, India. Now, with ...

Eli Lilly is partnering with the fabled venture capital firm Andreessen Horowitz on a new fund backed with $500 million of ...

The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the ...

SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO, January 09, 2025--Biocom California, the association representing the California life science industry, today announced that it appointed Aliza ...

GEMMA Biotherapeutics —a new therapeutics company founded by gene therapy pioneer Dr. Jim Wilson—has named May Orfali, MD, ...

WITT (Wellness in Travel and Tourism), a leader in wellness travel education, is excited to announce the launch of its introductory Wellness Foundations Course (101). Whether you're a travel advisor, ...

Peer Conversations explores successful leadership through the personal and professional choices of the most influential ...